BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35020661)

  • 1. Incidental Intrahepatic Hepatocellular Cholangiocarcinoma Detected on 68Ga-PSMA PET/CT.
    Kang C; Jiang JY; Lee ME; Shen L; Mansberg R
    Clin Nucl Med; 2022 Mar; 47(3):e291-e293. PubMed ID: 35020661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 68Ga-PSMA Uptake in Combined Hepatocellular Cholangiocarcinoma With Skeletal Metastases.
    Alipour R; Gupta S; Trethewey S
    Clin Nucl Med; 2017 Oct; 42(10):e452-e453. PubMed ID: 28806238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solitary Femoral Nodal Metastasis Identified With 68Ga-Prostate-Specific Membrane Antigen PET/CT.
    Hilliar L; Yip JWL; Wong VCK; Le K; Mansberg R
    Clin Nucl Med; 2021 Feb; 46(2):173-174. PubMed ID: 33315675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical Presentation of Liver Metastases of Prostate Cancer in 68Ga-PSMA-11 PET/CT.
    Stanzel S; Weitzer F; Janek E; Plhak E; Aigner RM
    Clin Nucl Med; 2023 Dec; 48(12):1064-1065. PubMed ID: 37934704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidental Prostate-Specific Membrane Antigen-Avid Vestibular Schwannoma Detected on 68 Ga-Prostate-Specific Membrane Antigen PET/CT.
    Chen J; Bui P; Bui C; Mansberg R
    Clin Nucl Med; 2024 Mar; 49(3):234-236. PubMed ID: 38271251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How accurate is
    Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F
    Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different Appearances of 3 Malignancies in 68Ga-PSMA-11 Versus 18F-FDG PET/CT.
    Weitzer F; Nazerani-Hooshmand T; Aigner RM; Pernthaler B
    Clin Nucl Med; 2021 Jul; 46(7):e358-e359. PubMed ID: 34081054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 68Ga-Prostate-Specific Membrane Antigen PET/CT in Cholangiocarcinoma: A Potential Biomarker for Targeted Radioligand Therapy?
    Marafi F; Usmani S; Esmail A
    Clin Nucl Med; 2019 Jul; 44(7):e439-e441. PubMed ID: 30985434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 68Ga-PSMA-11 PET/CT for prostate cancer staging and risk stratification in Chinese patients.
    Zang S; Shao G; Cui C; Li TN; Huang Y; Yao X; Fan Q; Chen Z; Du J; Jia R; Sun H; Hua Z; Tang J; Wang F
    Oncotarget; 2017 Feb; 8(7):12247-12258. PubMed ID: 28103574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing Meningioma From Metastasis of Prostate Cancer on 68Ga-PSMA PET/CT.
    Filizoglu N; Oksuzoglu K; Ozguven S
    Clin Nucl Med; 2021 Nov; 46(11):e553-e555. PubMed ID: 34606488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 68Ga-PSMA Uptake Patterns of Clear Cell Renal Carcinoma Across Different Histopathological Subtypes.
    Oflas M; Ozluk Y; Sanli O; Ozkan ZG; Kuyumcu S
    Clin Nucl Med; 2022 Jan; 47(1):e45-e46. PubMed ID: 34284482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 68Ga-PSMA Uptake in Brain Metastasis of Gastric Carcinoma.
    Kesim S; Oksuzoglu K
    Clin Nucl Med; 2022 Sep; 47(9):e585-e586. PubMed ID: 35930713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult Bone Metastases From Hepatocellular Carcinoma Detected on 68Ga-PMSA PET/CT.
    Usmani S; Rasheed R; Al Kandari F; Ahmed N
    Clin Nucl Med; 2021 Aug; 46(8):661-663. PubMed ID: 33512948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined hepatocellular carcinoma and cholangiocarcinoma with high F-18 fluorodeoxyglucose positron emission tomographic uptake.
    Shiomi S; Sasaki N; Kawashima D; Jomura H; Fukuda T; Kuroki T; Koyama K; Kawabe J; Ochi H
    Clin Nucl Med; 1999 May; 24(5):370-1. PubMed ID: 10232488
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19 Lung Findings Detected by 68Ga-PSMA PET/CT for Staging Purposes in Patients With Prostate Cancer.
    Karasah Erkek B; Ömür Ö; Özkök S; Turna B
    Clin Nucl Med; 2022 Jan; 47(1):e17-e19. PubMed ID: 34028424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 89Zr-PSMA-617 PET/CT May Reveal Local Recurrence of Prostate Cancer Unidentified by 68Ga-PSMA-11 PET/CT.
    Rosar F; Bartholomä M; Maus S; Privé BM; Khreish F; Franssen GM; Derks YHW; Nagarajah J; Ezziddin S
    Clin Nucl Med; 2022 May; 47(5):435-436. PubMed ID: 35234197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary lymph-node staging with
    Corona-Montes VE; González-Cuenca E; Fernández-Noyola G; Olarte-Casas MA; Bobadilla-Salazar D; Medrano-Urtecho HM; Asimakopoulos AD
    Urol Oncol; 2021 Aug; 39(8):494.e1-494.e6. PubMed ID: 33223371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET/CT With 68Ga-PSMA and 18F-FDG in Metastatic Adenoid Cystic Carcinoma: Report of 2 Cases.
    Isgoren S; Hekimsoy T; Koroglu E; Demir H
    Clin Nucl Med; 2022 May; 47(5):e423-e424. PubMed ID: 35234196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidental Detection of Hepatocellular Carcinoma on 68Ga-Labeled Prostate-Specific Membrane Antigen PET/CT.
    Patel D; Loh H; Le K; Stevanovic A; Mansberg R
    Clin Nucl Med; 2017 Nov; 42(11):881-884. PubMed ID: 28902734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is 68Ga-Prostate-Specific Membrane Antigen PET/CT Superior than 18F-FDG PET/CT for Evaluation of Metastatic Osteosarcoma?
    Can C; Gündoğan C; Kömek H
    Clin Nucl Med; 2021 Apr; 46(4):e233-e235. PubMed ID: 33031232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.